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Background: It has been reported that the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway regulates
erythropoietin (EPO)-induced survival, proliferation, and maturation of early erythroid progenitors. Erythroid cell
proliferation and survival have also been related to activation of the JAK-STAT pathway. The goal of this study was
to observe the function of EPO activation of JAK-STAT and PI3K/AKT pathways in the development of erythroid
progenitors from hematopoietic CD34+ progenitor cells, as well as to distinguish early EPO target genes in human
erythroid progenitors during ontogeny.
Methods: Hematopoietic CD34+ progenitor cells, isolated from fetal and adult hematopoietic tissues, were
differentiated into erythroid progenitor cells. We have used microarray analysis to examine JAK-STAT and PI3K/AKT
related genes, as well as broad gene expression modulation in these human erythroid progenitor cells.
Results: In microarray studies, a total of 1755 genes were expressed in fetal liver, 3844 in cord blood, 1770 in adult
bone marrow, and 1325 genes in peripheral blood-derived erythroid progenitor cells. The erythroid progenitor cells
shared 1011 common genes. Using the Ingenuity Pathways Analysis software, we evaluated the network pathways
of genes linked to hematological system development, cellular growth and proliferation. The KITLG, EPO, GATA1,
PIM1 and STAT3 genes represent the major connection points in the hematological system development linked
genes. Some JAK-STAT signaling pathway-linked genes were steadily upregulated throughout ontogeny (PIM1,
SOCS2, MYC, PTPN11), while others were downregulated (PTPN6, PIAS, SPRED2). In addition, some JAK-STAT pathway
related genes are differentially expressed only in some stages of ontogeny (STATs, GRB2, CREBB). Beside the
continuously upregulated (AKT1, PPP2CA, CHUK, NFKB1) and downregulated (FOXO1, PDPK1, PIK3CG) genes in the
PI3K-AKT signaling pathway, we also observed intermittently regulated gene expression (NFKBIA, YWHAH).
Conclusions: This broad overview of gene expression in erythropoiesis revealed transcription factors differentially
expressed in some stages of ontogenesis. Finally, our results show that EPO-mediated proliferation and survival of
erythroid progenitors occurs mainly through modulation of JAK-STAT pathway associated STATs, GRB2 and PIK3
genes, as well as AKT pathway-coupled NFKBIA and YWHAH genes.
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The regulation of erythropoiesis is a very complex
process requiring the coordination of different signaling
pathways and molecular reactions. Many transcription
factors controlling globin gene expression, such as
GATA binding proteins 1/2 (GATA1/2), Krüppel-like* Correspondence: vl@imi.bg.ac.rs
1Laboratory of Experimental Hematology, Institute for Medical Research,
University of Belgrade, Belgrade 11129, Serbia
Full list of author information is available at the end of the article
© 2012 Cokic et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfactor (KLF1), nuclear factor erythroid-derived 2 (NFE2),
have been identified and characterized. The erythroid-
specific transcription factor GATA1 is a direct activator
of the beta (β)-globin gene [1]. GATA1 homodimerizes
and interacts with other transcription factors, such as
erythroid KLF1 and friend of GATA1 (FOG), further
contributing to activation of delta (δ)-, gamma (γ)-, and
β-globin promoters [2]. KLF1 is a zinc finger transcrip-
tion factor that activates the β-globin gene promoter [3].
The protein FOG is co-expressed with GATA1 duringtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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was identified as a repressor of the epsilon (E)-globin
gene, it appears to prevent binding of KLF1 to the E-
globin gene promoter and silences E-globin expression
during definitive erythropoiesis [5]. Another erythroid-
specific transcription factor, called Kruppel-like factor 11
(KLF11), activates also γ- and E-globin genes in vitro [6].
In primitive erythropoiesis GATA2 is primarily
expressed, but later in ontogeny GATA1 expression pre-
dominates [7]. Downregulation of GATA2 is important
for progression of erythroid cell differentiation [8]. A nu-
clear protein, special AT-rich binding protein 1 (SATB1),
regulates genes through targeting chromatin remodeling
and increases E-globin and decreases γ-globin gene ex-
pression [9]. Activation of globin production by tran-
scription factor NFE2 is stimulated by cAMP-dependent
protein kinase (PKA) in erythroid cells [10].
Genome extensive profiling has been used in several
studies of erythroid differentiation [11-13]. Some of
these were primarily concerned about different stages of
erythropoiesis to recognize potential transcription fac-
tors regulating gene expression during terminal erythro-
poiesis [14]. Increased apoptotic activity has been found
for peripheral blood (PB)-derived hematopoietic pro-
genitor CD34+ cells compared to bone marrow (BM)-
derived CD34+ cells [15]. It has been reported that
erythropoietin (EPO) and stem cell factor (SCF)
mediated synergistic expansion of primary erythroid pre-
cursors activating JAK-STAT, phosphatidylinositol 3-
kinase (PI3K) and MAPK pathways [16]. Activation of
each of the JAK-STAT, MAPK p42/44 or PI3K-AKT
pathways alone is not sufficient either to stimulate cell
proliferation or inhibit apoptosis of human CD34+ cells
and erythroblasts. Erythroid proliferation appears more
related to simultaneous activation of JAK-STAT and
MAPK p42/44 whereas the effect on cell survival corre-
lates better with activation of PI3K-AKT, JAK-STAT and
MAPK p42/44 pathways. EPO and SCF inhibit apoptosis
of early erythroid CD34+ burst-forming units (BFU-E)
progenitors and erythroblasts [17]. In addition, the EPO
activation of JAK-STAT pathway has an important role
in inhibiting apoptosis of human hematopoietic cells,
similarly to the PI3K-AKT axis [18].
It has been reported that feeder layers of stroma from
human fetal liver (FL), cord blood (CB), and adult bone
marrow (BM) enhance CD34+ hematopoietic progenitor
cell proliferation and erythropoiesis [19]. We have exam-
ined the growth and erythroid differentiation capacity of
CD34+ cells only, already committed toward
hematopoiesis in fetal and adult hematopoietic cells.
Using this approach, we evaluated a broad range of
genes expressed in erythroid progenitors derived from
hematopoietic cells through ontogeny. The broad com-
parison of erythropoiesis-related signaling pathwayshighlighted statistically significant changes in gene
expression among the examined cells. Regarding its sig-
nificance, we choose to focus on JAK-STAT and PI3K-
AKT signaling pathways during erythroid differentiation.
The most prominent genes are v-myc (myelocytomatosis
viral oncogene homolog (MYC)) and pim-1 oncogene
(PIM1) in the JAK-STAT pathway, whereas in the PI3K-
AKT pathway emerge the heat shock protein 90 kDa
alpha (HSP90AA1) and protein phosphatase 2 alpha
(PPP2CA) genes. After activation of v-akt (murine thym-
oma viral oncogene homolog 1 (AKT1)), cell survival is
promoted via nuclear factor of kappa light polypeptide
gene enhancer in B-cells 1 (NFKB1) and conserved
helix-loop-helix ubiquitous kinase (CHUK) according to
its elevated gene expression in the PI3K-AKT pathway.
Activation of JAK-STAT pathway coupled genes is
observed via STATs and protein tyrosine phosphatase,
non-receptor type 11 (PTPN11) gene expression linked
to transcription regulation and differentiation. We de-
scribe upregulated and downregulated genes during eryth-
roid differentiation of hematopoietic progenitor cells, with
the emphasis on JAK-STAT and PI3K-AKT coupled genes,
to define the mechanism of erythropoiesis.
Methods
Liquid erythroid cell cultures
To follow erythropoiesis through ontogeny, we isolate
hematopoietic CD34+ progenitor cells from correspond-
ing fetal and adult hematopoietic tissues and stimulate
in vitro erythroid differentiation. Adult PB mononuclear
cells are isolated from buffy coats of three healthy
donors (NIH Blood bank) using Lymphocyte Separation
Medium (BioWhittaker, Walkersville, MD) and CD34+
cells are purified by positive immunomagnetic selection
with MACS cell isolation system (Miltenyi Biotec,
Auburn, CA). Commercial FL-derived CD34+ cells
(Cambrex Bio Science, Inc., Walkersville, MD), CB- and
BM-derived CD34+ cells (AllCells LLC, Berkeley, CA)
are also isolated by positive immunomagnetic selection
(Miltenyi Biotec). To stimulate erythroid differentiation,
the labeled CD34+ cells of all ontogenic stages are cul-
tured in the medium that contains 30% fetal bovine
serum (FBS), 2 mmol/L glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin, 10% deionized bovine serum
albumin, 10 mmol/L mercaptoethanol, 1 mmol/L dexa-
methasone, 33 μg/ml holo-transferrin, 10 ng/ml SCF,
1 ng/ml IL-3 and 1 ng/ml GM-CSF (Sigma, St. Louis,
MO), and 1 U/ml human recombinant EPO (Amgen
Inc, Thousand Oaks, CA) [20]. For microarray analysis,
erythroid progenitors are isolated at day 6 of erythroid
cell culture at 37°C and 5% CO2 with balanced 95% room
air. Anti-CD71 Tricolor is used for cell staining (Beck-
man-Coulter, Miami, FL). Cells are fixed in PBS contain-
ing 4% formaldehyde, and acquire on an LSRII flow
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lyzed with Flowjo software (Tree Star, San Carlos, CA).
Isolation of total RNA
We use the RNeasy protocol for isolation of total RNA
from erythroid progenitor cells (Qiagen, Valencia, CA)
according to the manufacturer's instructions. Concentra-
tion and integrity of total RNA is assessed using an 8453
UV/Visible Spectrophotometer (Hewlett-Packard GmbH,
Waldbronn, Germany) and Agilent 2100 Bioanalyzer Soft-
ware (Agilent Technologies, Waldbronn, Germany).
Microarray studies
In microarray studies, the numbers of total genes over-
expressed in erythroid cells of CB, BM and PB origin are
determined from three independent samples as bio-
logical repeats. On the other hand in case of FL-derived
samples, the number of total overexpressed genes is
determined in independent duplicate samples. High
quality oligonucleotide glass arrays are produced con-
taining a total of 16,659 seventy-mer oligonucleotides
chosen from 750 bases of the 3′ end of each ORF (Op-
eron Inc. Valencia, CA). The arrays are produced in
house by spotting oligonucleotides on poly-L-lysine
coated glass slides by Gene Machines robotics (Omni-
grid, San Carlos, CA). We have followed the MIAME
(minimum information about a microarray experiment)
guidelines for the presentation of our data [21].
Probe preparation
Total human universal RNA (HuURNA) isolated from a
collection of adult human tissues to represent a broad
range of expressed genes from both male and female
donors (BD Biosciences, Palo Alto, CA) serve as a uni-
versal reference control in the competitive hybridization.
All examined samples are hybridized against HuURNA.
The correlation coefficients among those biological
repeats themselves are consistently ≥ 0.8, which docu-
mented the quality of hybridization and consistency of
expression among the replicates of all examined eryth-
roid progenitors. Labeled cDNA probes are produced as
described [22]. Briefly, 5 μg of total RNA is incubated at
70°C for 5 minutes along with 1 μl of aminoallyl-oligo dT
primer and quickly chilled for 3 minutes. Then, 2 μl 10X
first strand buffer, 1.5 μl SSII enzyme (Stratagene, La
Jolla, CA), 1.5 μl 20X aminoallyl dUTP and 2 μl of 0.1 M
DTT are added and incubated for 90 minutes at 42°C.
After incubation, volume of the reaction mixture is raised
to 60 μl with 40 μl of DEPC water. cDNA is purified by
the MinElute column (Qiagen). 300 μl of Binding buffer
PB is added to the coupled cDNA, and the mixture ap-
plied to the MinElute column, and centrifuged for 1 mi-
nute at 10.000 rpm. After discharging the flow-through,
600 μl of washing buffer PE is added to the column, andcentrifuged for 1 minute at 10.000 rpm. The flow-
through is discharged and the washing repeated. Then
the columns are placed into a fresh eppendorf tube and
15 μl elution buffer added to the membrane, incubated
for 1 minute at room temperature, centrifuged for 1 mi-
nute at 10.000 rpm and probe collected. The probe is
dried in speed-vac for 16 minutes. Finally, 5 μl of 2X
coupling buffer and 5 μl Cy3 and Cy5 dye (GE Health-
care Bio-Sciences Corp., Piscataway, NJ) are mixed into
the control (HuURNA) and experimental cDNAs (huES
cell-derived) respectively and incubated at room
temperature in dark for 90 minutes. After incubation, the
volume is raised to 60 μl by 50 μl DEPC water and then
cDNA is purified by the MinElute column and eluted
with 13 μl elution buffer by centrifugation.
Hybridization
For hybridization, 36 μl hybridization mixture [26 μl
cDNA mixture, 1 μl (10 μg) COT-1 DNA, 1 μl (8–10
μg) poly(dA), 1 μl yeast total RNA (4 μg), 6 μl 20X SSC
and 1 μl 10% SDS] is pre-heated at 100°C for 2 minutes
and cooled for 1 minute. Total volume of probe is added
on the array and covered with cover slip. Slides are
placed in hybridization chamber and 20 μl water is
added to the slide, and incubated overnight at 65°C.
Slides are then washed for 2 minutes each in 2X SSC,
1X SSC and 0.1X SSC and spin-dried.
Data filtration, normalization, and analysis
Microarray slides are scanned in both Cy3 (532 nm) and
Cy5 (635 nm) channels using Axon GenePix 4000B
scanner (Axon Instruments, Inc., Foster City, CA) with a
10-micron resolution. Scanned microarray images are
exported as TIFF files to GenePix Pro 3.0 software for
image analysis. The raw images are collected at 16-bit/
pixel resolutions with 0 to 65,535 count dynamic range.
The area surrounding each spot image is used to calcu-
late a local background and subtracted from each spot
before the Cy5:Cy3 ratio calculation. The average of the
total Cy3 and Cy5 signal gives a ratio that is used to
normalize the signals. Each microarray experiment is
globally normalized to make the median value of the
log2-ratio equal to zero. The Loess normalization
process corrects for dye bias, photo multiplier tube volt-
age imbalance, and variations between channels in the
amounts of the labeled cDNA probes hybridized. The
data files representing the differentially expressed genes
are then created. For advanced data analysis, gpr and
jpeg files are imported into microarray database, and
normalized by software tools provided by NIH Center for
Information Technology (http://nciarray.nci.nih.gov/).
Spots with confidence interval of 99 (≥ 2 fold) with at
least 150-fluorescence intensity for both channel and
30 μm spot size are considered as good quality spots for
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expression data derived from 11 datasets that have been
posted on the National Center for Biotechnology Informa-
tion (NCBI) Gene Expression Omnibus (GEO) database.Statistical analysis
The one way ANOVA with Tukey's Multiple Compari-
son tests and paired t test are applied using Prism 4 soft-
ware (GraphPad Software Inc., San Diego, CA) for
measurement of statistical significance in microarray
analysis during ontogenesis. Ingenuity Pathways Analysis
is a software application that enables identification of
the biological mechanisms, pathways and functions most
relevant to the genes of interest [www.ingenuity.com].Results
Gene expression patterns in erythroid progenitor cells
during ontogeny
In the presence of EPO and other cytokines, CD34+
hematopoietic progenitor cells are differentiated in vitro
into erythroid progenitor cells. We already reported the
steady increase in adult hemoglobin and decline in fetal
hemoglobin levels during in vitro erythroid differenti-
ation of PB CD34+ cells [20]. At day 6 of erythroid cell
culture, the erythroid progenitor cells of examined onto-
logical stages are labeled as 100% CD71+ (a well-known
early marker of erythroid differentiation) are isolated for
microarray analysis. Moreover, we perform flow cytome-
try of three additional differentiation markers CD34,
CD36 and glycophorin A and despite variation in their
expression we did not find the statistical significance at
day 6 of erythroid culture (not shown). The total num-
ber of expressed genes per ontogenic stage, evaluated by
microarray analysis, is presented in Table 1 (first col-
umn). The microarray data discussed in this publication
we deposited in NCBI’s GEO database and are accessible
through GEO Series accession number GSE37869 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE37869).
Presence of individual genes in two-thirds of examined
samples per cell group (66% filtering) reduced largely the
total gene expression (second column, Table 1). The total
gene expression is more than doubled in erythroidTable 1 Number of total genes in examined cells and






≥ 1.5 fold ≥ 2 fold ≥ 3 fold
FL 5900 1755 150 43 10
CB 6667 3844 325 84 14
BM 7002 1770 247 90 13
PB 3794 1325 83 29 2
FL-fetal liver, CB-cord blood, BM-bone marrow, PB-peripheral blood.progenitor cells of CB-derived cells in comparison to other
cells. Adult PB-derived erythroid progenitor cells express
the least quantity of genes. A total of 43 genes were highly
expressed (two-fold and higher) in FL, 84 genes in CB, 90
in BM, and 29 genes in PB-derived erythroid progenitor
cells (Table 1). Overexpression of 1011 genes is common
in all cells during ontogeny (after 66% filtering). In
addition to globins, the common highly expressed genes
in erythroid progenitor cells are proteoglycan 2 (PRG2),
Charcot-Leyden crystal protein (CLC), serglycin (SRGN),
eosinophil peroxidase (EPX) and MYC. To examine effect
of FBS on erythropoiesis, we decide to follow erythropoi-
etic markers γ and β globins in the same in vitro erythroid
culture conditions with or without FBS. However, the re-
duction of γ globin gene expression and γ/β ratio did
not reach statistical significance in FBS-deprived culture
conditions (not shown).
Microarray analysis of gene expression profiles in
erythroid progenitor cells
To distinguish genes with statistically significant expres-
sion in erythroid progenitors through ontogeny we per-
form comparisons using the t-test (Table 2-4). During
microarray analysis genes are upregulated or downregu-
lated compared to HuURNA, used as a control
alongside each sample. We present upregulated genes
compared to HuURNA determined by t-test in Table 2.
The other statistically significant genes that have the
same pattern of expression, as genes in Table 2, are
presented in Additional file 1. The ERAF gene related to
erythroid differentiation and hematological system devel-
opment is upregulated in BM tissue (Table 2). The same
patterns of expression and ratio as ERAF gene are also
observed for the following genes: ENY2, GSTO1,
HMGB2, HPS4, HSD17B10, METTL13 (Additional file
1). We also separate downregulated genes compared to
HuURNA determined by t-test (Table 3, Additional file
2). The same pattern of expression, statistical signifi-
cance and ratio as GNB1 gene, elevated in CB-derived
cells, is also observed for the CYB5R3, ILF3 and NKX2-5
genes. The same patterns of expression and ratio as
PDGFRA gene, upregulated in BM tissue, are also
observed for the ERGIC1 and RAPSN genes (Additional
file 2). Some genes are differentially upregulated and
downregulated in various stages, so we present them
as special group of diverse genes in statistical analysis by
t-test (Table 4, Additional file 3). STAT5A and STAT5B
have the highest gene expression in BM-derived
erythroid cells (Tables 2). The same patterns of expres-
sion, statistical significance and ratio as STAT5B gene are
observed for the following genes: HIGD1A, KHSRP,
LYSMD3, SF1, SPEN, ACOT9, TACC3, VDAC2. Besides
statistical analysis performed by t-test between two
group of cells, we also make ANOVA analysis of the
Table 2 Statistically significant genes by t-test
up-regulated vs. HuURNA among examined cells. p< 0.01
(≤, ≥), p< 0.05 (<, >)
Gene
Name
Description vs. F F F C C B
C B P B P P
ABCE1 ATP-binding cassette, sub-family E memb. 1 <
ACLY ATP citrate lyase >
AP1B1 adaptor-related protein complex1,β1 subunit > <
ATP1B3 ATPase, Na+/K+ transporting, β3 polypeptide >
BAT2D1 BAT2 domain containing 1 >
BTF3L3 basic transcription factor 3-like 3 < >
CAPZA2 capping protein (actin fil.) muscle Z-line, α2 ≤
CLK2 CDC-like kinase 2 >
CORO1C coronin, actin binding protein, 1 C >< >
CSDE1 cold shock domain containing E1, RNA-bind <
DDOST dolichyl-diphosphooligos-prot glycosyltransf >>>
ECH1 enoyl Coenzyme A hydratase 1 peroxisomal ≤ ≤
ENO1 enolase 1, (alpha) >
ERAF erythroid associated factor <
FADS2 fatty acid desaturase 2 <
GOLIM4 golgi integral membrane protein 4 ≤
HDAC1 histone deacetylase 1 >
HSPA5 heat shock 70 kDa protein 5 > ≥
HSPA8 heat shock 70 kDa protein 8 >
LDHA lactate dehydrogenase A > >>
MYBL2 v-myb myeloblastosis viral oncog hom-like 2 <
NDUFAB1 NADH dehydrog ubiquinone 1 α/β subcomp1 < <
NFATC3 nucl fact of activ T-cel cytopl calcineur-dep 3 < <
PDIA6 protein disulfide isomerase family A m6 >
PPA1 pyrophosphatase (inorganic) 1 <
PSMB3 proteasome (prosome) subunit, β type, 3 >
RPL18A ORF > <
RPN1 ribophorin I > ≥
SERPINB1serpin peptidase inhibitor, clade B m1 ≥ ≥
STAT5A Signal transd. and activator of transcript. 5A <<
TFDP3 transcription factor Dp family, member 3 ≤ <
TIMM23 transl of inner mitoch memb 23 hom ngemp <
TPST2 tyrosylprotein sulfotransferase 2 <
TUBG1 tubulin, gamma 1 < ≤
TXNL1 thioredoxin-like 1 <
YWHAZ tyrosine 3-/tryptophan 5-monooxygenase zeta pp < ≤ >
ZNF224 zinc finger protein 224 ≤ <
ZNF43 zinc finger protein 43 < >
nuclear gene encoding mitochondrial protein (ngemp), member (m). Bolded
genes – expression >1.5 fold vs. HuURNA; F-fetal liver, C-cord blood, B-bone
marrow, P-peripheral blood.
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present them in Additional file 4. This extended statis-
tical analysis also reveal that HDAC1 and SERPINB1
genes are significantly increased in FL-derived erythroidprogenitor cells (Tables 2). HDAC2 gene expression is
largely increased throughout ontogeny with the highest
level also in FL-derived cells (not shown). Apoptotic
IGFBP7 gene is downregulated, mostly in adult derived
cells (Table 3). In addition, these ANOVA determined
genes are also shown in hierarchical clustering analysis,
as well as clustering of individual samples of all exam-
ined cells (Figure 1).
Pathways linked to hematological system development
Using the Ingenuity Pathways Analysis software, we
evaluate the network pathway of genes linked to
hematological system development (Figure 2). As shown
in Figure 2, KITLG (SCF), EPO, GATA1 and STAT3 rep-
resent the major junction points in hematological system
development. The effects of KITLG are only indirect to-
ward other related molecules, whereas STAT3 is the
major target point for direct or indirect effects of linked
molecules (Figure 2). In our microarray analysis, KITLG
and EPO gene expression are downregulated in BM- and
PB-, whereas STAT3 gene expression is slightly upregu-
lated in erythroid progenitor cells and more notably in
CB- and BM-derived cells. GATA1 gene expression is
considerably upregulated in all cells during ontogeny,
except a low level in FL-derived cells. KITLG and EPO
linked ERAF and UCP2 gene expression are increased
during ontogeny, but reached maximum in adult derived
cells (Table 2, Additional file 1). The expression of genes
related to hematological system development throughout
ontogeny (Figure 2) have the following characteristics:
WDR1 gene expression, induced by EPO and KITLG, is
decreased only in PB-derived cells, with the top level in
erythroid progenitor cells of FL origin (Table 4). EPX
gene expression is significantly upregulated in FL- and
CB-derived erythroid cells compared to PB-derived cells.
Rh-associated glycoprotein (RHAG) has decreased ex-
pression in BM-, whereas cytokine inducible SH2-
containing protein (CISH) and PIM1 have increased
expression in BM- and PB-derived erythroid cells. CLC,
colony stimulating factor 3 receptor (CSF3R), cleavage
and polyadenylation specific factor 3 (CPSF3) and small
GTP binding protein (RAB4A) genes have increased ex-
pression, whereas thioredoxin-like 1 (TXNL1) has
decreased expression in FL-derived erythroid progenitor
cells. EPO receptor (EPOR) gene expression is increased
in CB- and BM-derived erythroid cells. Regarding suc-
cinate dehydrogenase complex gene expression, subunit
A (SDHA) is also increased in FL-, subunit B (SDHB) in
CB- and BM-, subunit D (SDHD) in PB-, while subunit
C (SDHC) is decreased in BM-derived erythroid cells.
Proliferation and survival of erythroid cells
EPO stimulates the JAK-STAT pathway during erythroid
differentiation [16]. We also use EPO for erythroid
Table 3 Statistically significant genes by t-test down-
regulated vs. HuURNA among examined cells. p< 0.01
(≤, ≥), p< 0.05 (<, >)
Gene
Name
Description vs. F F F C C B
C B P B P P
ADRB3 adrenergic, β-3-, receptor <
ATP6C ATPase, H + transporting, lysosomal 16kD < >
BTBD10 BTB (POZ) domain containing 10 ≤
BTRC beta-transducin repeat containing >
CABP2 Calcium binding protein 2 >
CLEC4E C-type lectin domain family 4, member E ≥ ≥ >
COQ10B coenzyme Q10 homolog B (S. cerevisiae) < ≥
DVL3 dishevelled, dsh homolog 3 <
F2R coagulation factor II (thrombin) receptor >
FPR1 N-formylpeptide receptor fMLP-R98 ORF >
GSTM1 glutathione S-transferase mu 1 >
IGFBP7 insulin-like growth factor binding protein 7 ≥ > >
MINK1 Misshapen-like kinase 1 (zebrafish) <
MT1A metallothionein 1A <
NPIPL3 nuclear pore complex interact. protein-like 3 <
PDGFRA platelet-derived growth factor receptor, α < >
PDLIM1 PDZ and LIM domain 1 < ≥ >
PHLDA1 pleckstrin homology-like domain family A m1 >
PSMC4 proteasome (prosome) 26 S sub, ATPase, 4 >
SP2 Sp2 transcription factor > >
SQSTM1 sequestosome 1 < <
ST3GAL1 ST3 β-galactoside α-2,3-sialyltransferase 1 <
TIMP3 TIMP metallopeptidase inhibitor 3 > > > >
UBE2D3 ubiquitin-conjugating enzyme E2D 3 <
UBXN1 UBX domain protein 1 <
VAT1 vesicle amine transport protein 1 homolog > >
nuclear gene encoding mitochondrial protein (ngemp), member (m). Bolded
genes – expression >1.5 fold vs. HuURNA. F-fetal liver, C-cord blood, B-bone
marrow, P-peripheral blood.
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liquid cultures. We present JAK-STAT signaling pathway
related gene expression in Figure 3, as determined by
microarray analysis. Some JAK-STAT pathway related
genes are persistently upregulated throughout ontogeny
(PIM1, SOCS2, MYC, PTPN11), while others are downre-
gulated (PTPN6, PIAS3 and 4, SPRED2). Besides these
steady genes, some JAK-STAT pathway related genes are
variously regulated during ontogeny (STATs, GRB2,
CREBB, etc.). STAT1 and STAT5A gene expression is
upregulated throughout ontogeny reaching maximum in
erythroid progenitors of BM origin. STAT5B and STAT6
gene expression is downregulated in most ontogenic
stages reaching slightly positive values only in erythroid
progenitors of BM- and FL-derived cells, respectively. The
growth factor receptor-bound protein 2 (GRB2)demonstrates upregulation in erythroid cells of FL and
BM origin compared to its downregulation in CB- and
PB-derived cells. The enzymes phosphoinositide-3-kinase
(PIK3), catalytic, gamma polypeptide (PIK3CG) and PIK3,
regulatory subunit 2 (PIK3R5) are downregulated in all
hematopoietic cells during ontogeny, whereas PIK3R2 is
downregulated only in BM-derived cells and upregulated
in other hematopoietic cells. CREB binding protein
(CREBBP) gene expression is absent in PB-, but has the
highest elevation in FL- and CB-derived erythroid cells.
BCL2-like 1 (BCL2L1) gene expression is downregulated
in CB-derived cells and increased in other cells, mostly in
PB-derived erythroid cells. SOS1 gene expression is
increased in CB- and BM-derived cells.
Phosphorylation of AKT, a signaling molecule down-
stream of PI3K, is observed following SCF treatment
[16]. We use SCF in medium of our liquid cultures to
induce erythroid differentiation of hematopoietic pro-
genitors, together with EPO and cocktail of cytokines.
We present PI3K-AKT signaling pathway related gene
expression in Figure 4, as determined by microarray ana-
lysis. Beside continuously upregulated (AKT1, PPP2CA,
CHUK, NFKB1, etc) and downregulated (FOXO1,
PDPK1, PIK3CG) genes in the PI3K-AKT signaling path-
way, we observe intermittently regulated gene expres-
sion (YWHAH, NFKBIA). Tyrosine 3-monooxygenase/
tryptophan 5-monooxygenase activation protein (YWHAH)
gene expression is absent in erythroid progenitors of FL
origin, downregulated in CB- and BM-, and not changed
in PB-derived cells. Nuclear factor of kappa light polypep-
tide gene enhancer in B-cells inhibitor, alpha (NFKBIA)
gene expression is upregulated in erythroid progenitors of
CB origin, downregulated in FL- and BM-, and not chan-
ged in PB-derived cells. HSP90AA1 has the most increased
expression of all PI3K-AKT pathway related genes, con-
tinuously increasing expression from fetal- to adult-derived
erythroid cells. In contrast, upregulated PPP2CA gene ex-
pression demonstrates continuous decrease from fetal- to
adult-derived erythroid cells.
Discussion
We present the number of genes overexpressed in eryth-
roid progenitor cells from several ontogenic stages. The
total gene expression in erythroid progenitor cells of
CB-derived tissues is twice that in other examined cells.
These erythroid progenitor cells share 1011 common
genes in cells derived from all examined ontogenic
stages. We perform statistical analysis of the common
genes among examined ontogenic stages and determine
significant HDAC1 and SERPINB1 upregulation in FL-
derived and significant ERAF, STAT5A upregulation in
adult cells-derived erythroid progenitors. ERAF gene ex-
pression is directed by EPO and SCF activity, while
STAT5A promote proliferation and growth of erythroid
Table 4 Statistically significant by t-test genes down-/
up-regulated vs. HuURNA among examined cells. p< 0.01
(≤, ≥), p< 0.05 (<, >)
Gene
Name
Description vs. F F F C C B
C B P B P P




BRP44 brain protein 44 < ≤ ≤
CD24 CD24 molecule > >
CDK2AP2 cyclin-dependent kinase 2
associated prot. 2
> < <
CLTA clathrin, light chain (Lca) ≤
COMT catechol-O-methyltransferase ≥ ≥
CORO1A coronin, actin binding protein, 1A ≥
GADD45A growth arrest and
DNA-damage-inducible α
< <
ITGB2 integrin, beta 2 >
KIFC1 HSET mRNA for kinesin-related protein <
LSR lipolysis stimulated lipoprotein receptor ≥
PSMB6 proteasome (prosome) subunit,
β type, 6
<
SMAP2 small ArfGAP2 < <
SMARCA2 SWI/SNF related, matrix associated,
actin depend regul of chromat,
subfam a, memb 2
> >
STAT6 signal transd & activat of transcr 6,
IL-4 ind
> ≥
THYN1 thymocyte nuclear protein 1 <
TMX2 thioredoxin-related transmembrane protein 2 <
TPSB2 tryptase beta 2 < < <
VASP vasodilator-stimulated phosphoprotein ≥
VIM vimentin > >
WDR1 WD repeat domain 1 ≥ > ≥
XBP1 X-box binding protein 1 > ≥ > ≥
nuclear gene encoding mitochondrial protein (ngemp), member (m). Bolded
genes – expression >1.5 fold vs. HuURNA. F-fetal liver, C-cord blood, B-bone
marrow, P-peripheral blood.
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functional categorization by Ingenuity Pathways analysis
with the network of genes linked to hematological sys-
tem development. This analysis reveal the KITLG, EPO,
GATA1, PIM1 and STAT3 genes as the most important
interaction points for activity of related genes involved
in hematological development.
We focus our presentation of microarray results on
pathways linked to hematological system development,
cellular growth and proliferation. Besides already men-
tioned meeting point genes (GATA1, EPO), we describe
genes differentially expressed in some stages of ontogeny
(ERAF, PIM1). The phosphorylation of GATA1 is im-
portant for EPO-induced maturation of fetal liver eryth-
roid progenitor cells [23]. The role of GATA1 interminal erythroid differentiation includes suppression
of GATA2 expression and upregulation of erythroid-
specific target genes including those for KLF1, NFE2 and
EPOR. GATA1 gene expression was low in our FL-
derived erythroid cells, in contrast to other stages of on-
togeny. ERAF is an erythroid-specific protein, with low
levels in erythroid cells of FL-origin and high levels in
BM-derived cells. In addition, HDAC1 and HDAC2
stimulation of cell proliferation is mediated by STAT3
[24], while HDACs gene expression is elevated in eryth-
roid progenitors during ontogeny demonstrating import-
ance in early stages of ontogeny. PIM family genes have
a role in signal transduction in blood cells, contributing
to both cell proliferation and survival. A recent report
suggests that the PIM family genes, implicated in
cytokine-dependent signaling in hematopoietic cells, are
related to RUNX genes which regulate cell proliferation
and differentiation in ontogeny [25]. Runx1 is reported
to play an early role in hematopoietic development, and
we detect its increased gene expression in CB-derived
erythroid cells [26].
According to previous reports, the PI3K-AKT signaling
pathway regulates EPO-induced survival, proliferation,
and maturation of early erythroid progenitors [27,28].
PI3K prevents apoptosis and stimulate cell proliferation
in response to EPO stimulation in erythroid progenitors
[29]. Both EPO and SCF induce activation of PI3K, more-
over SCF causes activation of anti-apoptotic AKT, a sig-
naling molecule downstream of PI3K [16,30]. In
presented AKT signaling pathway, we demonstrate that
CB-derived erythroid cell survival is related to upregu-
lated NFKBIA gene, while FL-derived erythroid cell sur-
vival is linked to upregulated NFKB1 and PPP2CA genes.
Moreover, BM- and PB-derived erythroid cell survival is
associated with elevated HSP90AA1 gene expression.
Influence of FBS and cytokines on in vitro erythropoi-
esis has been observed in previous studies. It has been
studied GM-CSF and IL-3 effects on adult human eryth-
roid progenitors, stimulated to terminal differentiation
by EPO, under FBS-supplemented or FBS-deprived cul-
ture conditions. Although hemoglobinization and matur-
ation of BFU-E-derived erythroblasts was comparable in
FBS-replete versus FBS-deprived cultures, the latter had
significantly less γ-globin gene expression. Factors
present in FBS appear to exert a dominant influence on
fetal globin synthesis in vitro [31]. Both GM-CSF and
IL-3 exhibit erythroid burst-promoting activity in FBS-
deprived cultures, but IL-3 is more active [32]. Fetal calf
serum (FCS) is known to elevate γ-globin mRNA levels
and fetal hemoglobin in BFU-E culture; removal of FCS
from the BFU-E cultures did not significantly reduce γ-
globin mRNA levels [33]. FCS factors, responsible for
fetal hemoglobin increase, act at both early and late
stages of erythroid differentiation [34].
Figure 1 Hierarchical clustering of genes expressed during ontogeny. Hierarchical clustering of statistically significant genes determined by
ANOVA and expressed during ontogeny (left side). The color indicates the relative fold expression of each gene, with red indicating higher
expression, green indicating negative expression, black representing not changed expression, while gray stands for absent expression per each
examined sample. The total gene expression of erythroid progenitor cells from various cells is also clustered (above image) representing
similarities among various cells.
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of transcription factor/signaling protein STAT5A in
human hematopoietic stem and progenitor cells favored
their erythroid differentiation [35]. Increased STAT5A
gene expression is present throughout ontogeny and
reached a peak in BM-derived erythroid cells. The
tyrosine phosphorylation of STAT5, a downstream tar-
get for the non-receptor tyrosine kinase, JAK2, is
mediated by EPO [16,17]. The EPOR gene has more
than double expression in CB-derived erythroid cells in
comparison to PB-derived cells according to our
microarray analysis. CREB1 is significantly elevated
only in erythroid progenitor cells of FL origin, com-
pared to other ontogenic stages. The protein tyrosine
phosphatase family (PTP) contains signaling moleculesthat regulate cell growth and differentiation. PTPN11
gene expression is elevated throughout ontogeny,
reaching maximum in erythroid progenitors of BM ori-
gin. According to JAK-STAT pathway related gene ex-
pression in erythroid progenitors during different
periods of ontogeny, we demonstrate the antiapoptotic
mechanism regulated by PIK3R2 (increased in fetal
derived cells) and BCL2L1 (increased in adult derived
cells). The same apply for growth and proliferation
where largely increased PIM1, STAT1 and STAT5A
gene expression is present throughout ontogeny and
particularly in BM-derived erythroid progenitors.
MAPK signaling pathway has been regulated by
PTPN11 (BM-derived), GRB2 (FL- and BM-derived)
and SOS (CB-derived cells) gene interaction.
Figure 2 Hematological system development, cellular growth and proliferation. Using Ingenuity Pathways Analysis software we created the
network pathway of genes related to hematological system development. White nodes represent expressed genes in some stages, while gray
nodes represent genes expressed in all stages throughout ontogeny. The intensity of gray color is in positive correlation with a level of gene
expression in erythroid progenitors.
Figure 3 JAK-STAT signaling pathway. The expression of genes linked to JAK-STAT signaling pathway through ontogeny. (+p)
phosphorylation, (−p) dephosphorylation, ! stimulation, ? inhibition, ! translocation, # decreased gene expression, " increased gene
expression.
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Figure 4 AKT signaling pathway. The expression of genes linked to AKT signaling pathway through ontogeny. (+p) phosphorylation, !
stimulation, ! translocation.
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This ontogenic overview of specific genes and transcrip-
tional programs in normal erythropoiesis may contribute
to understanding of erythropoietic progenitor cell devel-
opment. It may form the basis for modifications of gene
expression in any kind of hematological malignancies as
well as in other diseases affecting erythropoiesis, and
more broadly, hematopoiesis. It will be important to ex-
tend this study of analyzed signaling pathways, from the
gene expression level to protein expression and phos-
phorylation levels. Affirmation of examined genes on
both levels will support the significance of our results.
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